^Blagg, Julian; Allerton, Charlotte M.N.; Batchelor, David V.J.; Baxter, Andrew D.; Burring, Denise J.; Carr, Christopher L.; Cook, Andrew S.; Nichols, Carly L.; Phipps, Joanne; Sanderson, Vivienne G.; Verrier, Hugh; Wong, Stephen (2007-12-15). „Design and synthesis of a functionally selective D3 agonist and its in vivo delivery via the intranasal route”.Bioorganic & Medicinal Chemistry Letters.17 (24): 6691—6.PMID17976986.doi:10.1016/j.bmcl.2007.10.059.
^Brioni, Jorge D.; Moreland, Robert B. (2006). „Dopamine D4 receptors and the regulation of penile erection”.Drug Discovery Today: Therapeutic Strategies.3 (4): 599—604.doi:10.1016/j.ddstr.2006.10.006.
^Attkins, N. J.; Heatherington, A. C.; Phipps, J.; Verrier, H.; Huyghe, I. (јул 2009). „Predictability of intranasal pharmacokinetics in man using pre-clinical pharmacokinetic data with a dopamine 3 receptor agonist, PF-219061”.Xenobiotica; the Fate of Foreign Compounds in Biological Systems.39 (7): 523—33.PMID19480558.S2CID26474660.doi:10.1080/00498250902893775.CS1 одржавање: Формат датума (веза)
Y
